Comparison of mechanical circulatory support with venoarterial extracorporeal membrane oxygenation or Impella for patients with cardiogenic shock: a propensity-matched analysis.
Konstantinos KaratoliosGeorgios ChatzisBirgit MarkusUlrich LuesebrinkHolger AhrensDimitar DivchevStyliani SyntilaAndreas JerrentrupBernhard SchiefferPublished in: Clinical research in cardiology : official journal of the German Cardiac Society (2020)
In this retrospective analysis of patients with CS, treatment with Impella 2.5/CP or vaECMO was associated with similar hospital and 6-month survival rates. Device-related access-site vascular complications occurred more frequently in the vaECMO group. A randomized trial is warranted to examine the effects of these devices on outcomes and to determine the optimal device choice in patients with CS.